ModelEdge
Ligand Pharmaceuticals Inc
LGND
Filing type
8-K
Filing date
Jun 24, 2026
Updated
Jun 26, 2026 ยท 5:55 AM

Filing

8-KMaterial Contracts, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sales of Equity Securities, Other Events

Exhibits

EX-4.1EX-4.1EX-10.1EX-10.1EX-10.2EX-10.2EX-99.1Material Contracts, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sales of Equity Securities, Other EventsEX-99.2Material Contracts, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sales of Equity Securities, Other EventsGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphic